SHEILA ROHE: Open Payments
NPI 1972936516 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 8 payments from 7 companies in 2025. Trend: 2023 $235 · 2024 $687 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $140 |
| Amgen Inc. | 1 | $102 |
| Neurocrine BioSciences, Inc. | 1 | $83 |
| COLOPLAST CORP | 1 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $73 |
| Galderma Laboratories, L.P. | 2 | $34 |
| REVANCE THERAPEUTICS, INC. | 1 | $18 |
Products named: KRYSTEXXA, INGREZZA, Titan, DAXXIFY.
Industry payments across MD — which companies pay providers there.
